DK176010B1 - Medikament-lipid-systemer med lav toxicitet - Google Patents

Medikament-lipid-systemer med lav toxicitet Download PDF

Info

Publication number
DK176010B1
DK176010B1 DK198900980A DK98089A DK176010B1 DK 176010 B1 DK176010 B1 DK 176010B1 DK 198900980 A DK198900980 A DK 198900980A DK 98089 A DK98089 A DK 98089A DK 176010 B1 DK176010 B1 DK 176010B1
Authority
DK
Denmark
Prior art keywords
lipid
drug
amphotericin
composition according
bioactive agent
Prior art date
Application number
DK198900980A
Other languages
Danish (da)
English (en)
Other versions
DK98089D0 (da
DK98089A (da
Inventor
Andrew S Janoff
Robert P Lenk
Lawrence Boni
Thomas Madden
Pieter R Cullis
John J Kearns
Anthony G Durning
Robert Klimchak
Joel Portnoff
Original Assignee
Zeneus Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27361805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK176010(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeneus Pharma Ltd filed Critical Zeneus Pharma Ltd
Publication of DK98089D0 publication Critical patent/DK98089D0/da
Publication of DK98089A publication Critical patent/DK98089A/da
Application granted granted Critical
Publication of DK176010B1 publication Critical patent/DK176010B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B2227/00—Photographic printing apparatus
    • G03B2227/32—Projection printing apparatus, e.g. enlarging apparatus, copying camera
    • G03B2227/325—Microcapsule copiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Vehicle Step Arrangements And Article Storage (AREA)
  • Catalysts (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
DK198900980A 1987-03-05 1989-03-01 Medikament-lipid-systemer med lav toxicitet DK176010B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US2215787A 1987-03-05 1987-03-05
US2215787 1987-03-05
US6990887A 1987-07-06 1987-07-06
US6990887 1987-07-06
US7930987A 1987-07-29 1987-07-29
US7930987 1987-07-29
US8800647 1988-03-03
PCT/US1988/000647 WO1988006443A1 (fr) 1987-03-05 1988-03-03 Systemes a base de medicament-lipide a basse toxicite

Publications (3)

Publication Number Publication Date
DK98089D0 DK98089D0 (da) 1989-03-01
DK98089A DK98089A (da) 1989-03-01
DK176010B1 true DK176010B1 (da) 2005-11-28

Family

ID=27361805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900980A DK176010B1 (da) 1987-03-05 1989-03-01 Medikament-lipid-systemer med lav toxicitet

Country Status (20)

Country Link
EP (1) EP0282405B2 (fr)
KR (1) KR970002870B1 (fr)
CN (1) CN1044093C (fr)
AT (1) ATE118169T1 (fr)
AU (1) AU622405B2 (fr)
CA (1) CA1338701C (fr)
DE (1) DE3852961T3 (fr)
DK (1) DK176010B1 (fr)
ES (1) ES2070131T5 (fr)
FI (1) FI102724B1 (fr)
GR (1) GR3015916T3 (fr)
HK (1) HK1007495A1 (fr)
IE (1) IE67152B1 (fr)
IL (1) IL85607A (fr)
LU (1) LU88684I2 (fr)
NL (1) NL990004I1 (fr)
NO (4) NO179995C (fr)
NZ (1) NZ223660A (fr)
PT (1) PT86913B (fr)
WO (1) WO1988006443A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
AU598958B2 (en) 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
CA2050679C (fr) * 1989-03-31 1998-09-22 Francis C. Szoka, Jr. Preparation de liposomes et de composes lipidiques
US5188951A (en) * 1990-04-17 1993-02-23 The Liposome Company, Inc. Enzymatic synthesis of soluble phosphatides from phospholipids
DE4108903A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Pharmazeutisches produkt
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
WO1992007571A1 (fr) * 1990-11-06 1992-05-14 Nippon Shinyaku Co., Ltd. Procede de production d'une emulsion grasse
EP0599977A1 (fr) * 1991-08-14 1994-06-08 SEQUUS PHARMACEUTICALS, INC. (a Delaware Corporation) Procede de traitement contre le vih avec de l'amphotericine b a faible toxicite
JPH08510748A (ja) * 1993-05-21 1996-11-12 ザ リポソーム カンパニー、インコーポレーテッド リポソームが誘発する生理的副作用の低減
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5902604A (en) 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
WO2007067784A2 (fr) * 2005-12-08 2007-06-14 Wyeth Compositions liposomales
KR101132626B1 (ko) * 2009-10-12 2012-04-02 주식회사 녹십자 난용성 약물의 전달을 위한 고밀도지단백 나노입자의 제조방법
AU2010359346B2 (en) 2010-08-20 2015-01-29 Dr. Reddy's Laboratories Sa Phospholipid depot
ES2640756T3 (es) 2010-10-22 2017-11-06 Dr. Reddy's Laboratories Sa. Uso de depósitos de fosfolipidos viscosos estables para tratar heridas
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
WO2016205384A1 (fr) 2015-06-15 2016-12-22 The University Of Washington Composition de nanoparticules lipidiques comprenant de multiples médicaments et procédés associés permettant d'obtenir une plage étendue de concentrations de médicaments dans le sang et les tissus lymphatiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4436746A (en) * 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration

Also Published As

Publication number Publication date
ES2070131T3 (es) 1995-06-01
NO1998012I1 (no) 1998-03-25
KR970002870B1 (ko) 1997-03-12
ES2070131T5 (es) 1998-10-01
NO944071D0 (no) 1994-10-26
DK98089D0 (da) 1989-03-01
DE3852961D1 (de) 1995-03-23
NO1998013I1 (no) 1998-03-25
NO884391L (no) 1988-11-24
CN1044093C (zh) 1999-07-14
EP0282405A3 (en) 1989-01-04
DE3852961T2 (de) 1995-07-06
EP0282405B1 (fr) 1995-02-08
CA1338701C (fr) 1996-11-12
DK98089A (da) 1989-03-01
NZ223660A (en) 1990-11-27
EP0282405A2 (fr) 1988-09-14
AU622405B2 (en) 1992-04-09
IL85607A0 (en) 1988-08-31
FI102724B (fi) 1999-02-15
IE67152B1 (en) 1996-03-06
GR3015916T3 (en) 1995-07-31
KR890700341A (ko) 1989-04-24
LU88684I2 (fr) 1996-04-29
NO180147C (no) 1997-02-26
HK1007495A1 (en) 1999-04-16
EP0282405B2 (fr) 1998-07-22
NO180147B (no) 1996-11-18
PT86913B (pt) 1993-07-30
WO1988006443A1 (fr) 1988-09-07
NO944071L (no) 1988-11-24
DE3852961T3 (de) 1998-12-24
FI102724B1 (fi) 1999-02-15
NO884391D0 (no) 1988-10-04
PT86913A (pt) 1989-03-30
NL990004I1 (nl) 1999-04-01
CN88101864A (zh) 1988-09-28
FI894161A0 (fi) 1989-09-04
ATE118169T1 (de) 1995-02-15
IE880600L (en) 1988-09-05
IL85607A (en) 1992-08-18
AU1799088A (en) 1988-09-26
NO179995B (no) 1996-10-21
NO179995C (no) 1997-01-29

Similar Documents

Publication Publication Date Title
DK176010B1 (da) Medikament-lipid-systemer med lav toxicitet
US6406713B1 (en) Methods of preparing low-toxicity drug-lipid complexes
US5616334A (en) Low toxicity drug-lipid systems
JP2882607B2 (ja) リポソーム性抗腫瘍剤の高薬剤：脂質調剤
EP0191824B1 (fr) Encapsulement d'agents antineoplastiques dans des liposomes
Vemuri et al. Preparation and characterization of liposomes as therapeutic delivery systems: a review
EP0231261B1 (fr) Liposomes multilamellaires presentant une efficacite de capture amelioree
US5380531A (en) Accumulations of amino acids and peptides into liposomes
EP1800665A2 (fr) Suspensions liposomales ultramicroniques obtenues à partir de lyophilisats préliposomaux
WO1990014074A1 (fr) Formulations liposomiques ameliorees de nucleotides et d'analogues de nucleotides
CN112004527A (zh) 用于治疗肺部疾病的可吸入脂质体缓释组合物
DE4216644B4 (de) Liposomen enthaltende Arzneimittel
EP0472639A1 (fr) Accumulation de medicaments dans des liposomes au moyen d'un gradient protonique
JP2006510674A (ja) 脂質：エモジン製剤に関する組成物および方法
US20060030578A1 (en) Pharmaceutically active lipid based formulation of irinotecan
JPH05503521A (ja) 指状突起―融合リポソームおよびゲル
US20020119170A1 (en) Low toxicity drug-lipid systems
JP2705175B2 (ja) 低毒性薬剤‐脂質系
HU209647B (en) Process for production of low toxicity composition containing bioactive agent and lipid
Yadav et al. Nanotechnology Integration in Proniosomal Drug Delivery System
JPH04126545A (ja) リポソームの製造法

Legal Events

Date Code Title Description
AGE Re-establishment of rights: approved
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2006 00014

Filing date: 20060524

Expiry date: 20100209

CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: AMPHOTERICIN B, LIPID KOMPLEKS

Spc suppl protection certif: CA 2006 00014

Filing date: 20060524

PUP Patent expired